Clarity Pharmaceuticals Ltd (ASX:CU6)

Clarity Pharmaceuticals Revenue

Clarity Pharmaceuticals had revenue of 5.81M AUD in the half year ending December 31, 2025, with 7.15% growth. This brings the company's revenue in the last twelve months to 10.58M, down -1.83% year-over-year. In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M, down -17.76%.

• Revenue (ttm): 10.58M
• Revenue Growth: -1.83%
• P/S Ratio: 103.80
• Revenue / Employee: 120.23K
• Employees: 88
• Market Cap: 1.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	9.46M	-2.04M	-17.76%
Jun 30, 2024	11.51M	1.71M	17.41%
Jun 30, 2023	9.80M	3.34M	51.74%
Jun 30, 2022	6.46M	3.26M	102.06%
Jun 30, 2021	3.20M	407.65K	14.62%